Showing results (141-150 of 170) with videos related to
Sort By:
Pageof 17
The Oncologist|September 25, 2009
Plasma fibrinogen levels and prognosis in patients with ovarian cancer: a multicenter studyStephan Polterauer, Christoph Grimm, Veronika Seebacher, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
Serum C-reactive protein as independent prognostic variable in patients with ovarian cancerLukas A Hefler, Nicole Concin, Gerda Hofstetter, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 31, 2018
Uterine and Tubal Lavage for Earlier Cancer Detection Using an Innovative Catheter: A Feasibility and Safety StudyElisabeth Maritschnegg, Florian Heitz, Nina Pecha, et al.Gynecologic Oncology|March 28, 2012
External validation of a nomogram predicting overall survival of patients diagnosed with endometrial cancerStephan Polterauer, Qin Zhou, Christoph Grimm, et al.Archives of Gynecology and Obstetrics|March 12, 2025
Intergroup-statement: statement of the german ovarian cancer commission, the North-Eastern German Society of gynecological Oncology (NOGGO), AGO Austria and AGO Swiss regarding the use of homologous repair deficiency (HRD) assays in advanced ovarian cancerLukas Chinczewski, Philipp Harter, Lukas Heukamp, et al.Cell Reports. Medicine|July 9, 2024
Combination of compound screening with an animal model identifies pentamidine to prevent Chlamydia trachomatis infectionKatja Knapp, Romana Klasinc, Anna Koren, et al.Scientific Reports|June 2, 2026
A homoeriodictyol sodium mouthwash reduces bitterness sensitivity in patients with gynecological cancer receiving carboplatin-based chemotherapySofie Zehentner, Agnes Mistlberger-Reiner, Elisabeth Wachter, et al.Plos One|May 12, 2016
Multiparametric [18F]Fluorodeoxyglucose/ [18F]Fluoromisonidazole Positron Emission Tomography/ Magnetic Resonance Imaging of Locally Advanced Cervical Cancer for the Non-Invasive Detection of Tumor Heterogeneity: A Pilot StudyKatja Pinker, Piotr Andrzejewski, Pascal Baltzer, et al.Molecular Cancer|March 25, 2014
Ambivalent role of pFAK-Y397 in serous ovarian cancer--a study of the OVCAD consortiumStefanie Aust, Katharina Auer, Anna Bachmayr-Heyda, et al.Gynecologic Oncology|June 26, 2019
Low anterior resection syndrome (LARS) in patients with epithelial ovarian cancer after primary debulking surgeryMarlene Kranawetter, Beyhan Ataseven, Christoph Grimm, et al.Pageof 17